drugset / Trial / NCT04499950
Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study
Phase 2
Completed
53 enrolled
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
American Institute for Cancer Research · collabBreast Cancer Research Foundation · collabHopkins-WellSpan Cancer Research Fund · collab
Non-randomizedSequentialSingle-blindOther
Summary
This is a single arm phase II study designed to determine the effects of pharmacotherapy and a remote behavioral weight loss intervention on weight loss in breast cancer survivors who are overweight or obese, and the impact of successful weight loss on serum biomarkers and gut microbiome.
Timeline
- Start
- 2021-02-08
- Primary completion
- 2024-01-10
- Completion
- 2024-01-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Contrave | Unknown | — | — |